Method for the redistribution of silicon-bonded groups
Patent Information
- Application Number
- PCT/US2026/018496
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-03-11
- Filing Date
- 2026-03-10
- Publication Date
- 2026-11-12
AI Technical Summary
The existing methods for forming silicon-carbon bonds in silane molecules are energy-intensive and inefficient, leading to significant energy losses and the production of undesirable byproducts, with a desire for more Me3SiCl as an end-blocker for organopolysiloxane polymerization.
A method involving the combination of an organosilicon component and a boron cluster catalyst to facilitate the exchange of silicon-bonded alkyl groups with silicon-bonded halogen atoms, using a boron cluster catalyst to form a target organosilicon compound.
This approach reduces energy requirements and enhances efficiency by selectively preparing the target organosilicon compound in desirable yields, addressing the inefficiencies of traditional methods.
Abstract
Description
METHOD FOR THE REDISTRIBUTION OF SILICON-BONDED GROUPSCROSS-REFERENCE TO RELATED APPLICATIONS
[0001] This application claims priority to and all advantages of U.S. Provisional Patent Application No. 63 / 769,745 filed on 11 March 2025, the content of which is incorporated herein by reference.FIELD OF THE INVENTION
[0002] The present disclosure relates generally to a method of facilitating an exchange of one silicon-bonded alkyl group of a first silane molecule with a silicon-bonded halogen atom of a second silane molecule, and more specifically, to a method of exchanging the silicon-bonded alkyl group with a silicon-bonded halogen atom by combining an organosilicon component and a catalyst comprising a boron cluster, and a reaction product comprising a target compound prepared in accordance with the same.DESCRIPTION OF THE RELATED ART
[0003] Catalysts are known in the art and are utilized in myriad industrial and commercial processes. Although most industrial and commercial catalysts have been identified and optimized over time, energy requirements and desire for efficiency remain significant.
[0004] For example, catalysts are utilized in making and ultimately using various silanes and organosilicon compounds. However, the creation of a silicon-carbon bond requires significant energy. To form silicon-methyl bonds, SiO2 is first carbothermally reduced to Si, which is thermodynamically inefficient due to energy losses and incomplete conversion of raw materials. Si is then reacted with MeCl in the presence of a copper catalyst package in the Mueller-Rochow direct process.
[0005] Not only is the direct process energy intensive, but production of byproducts further reduces overall efficiency. The main product of the direct process is dimethyldichlorosilane (~85%), with the next highest components being MeSiCl3 and Me3SiCl. Industry often desires more Me3SiCl as an end-blocker for organopolysiloxane polymerization. MeSiCl3 is typically produced in excess. Increasing production of Me3SiCl via the direct process also results in greater production of MeSiCl3.BRIEF SUMMARY
[0006] The present disclosure provides a method of preparing a target compound. The method comprises the step of combining (A) an organosilicon component and (B) a catalyst comprising a boron cluster to give a mixture. The boron cluster comprises a plurality of boron atoms and one carbon atom. The method further comprises preparing a reaction mixture comprising the target compound from the mixture. The organosilicon component (A) comprises (A1) a first organosilicon compound having at least one silicon-bonded C1-C4 alkyl group and optionally at least one silicon-bonded halogen atom. When the first organosilicon compound (A1) does not include a silicon-bonded halogen atom, the organosilicon component (A) further comprises a second organosilicon compound (A2) including at least one silicon-bonded halogen atom.
[0007] The target compound is different from the first organosilicon compound (A1) and, if utilized, the second organosilicon compound (A2). The catalyst (B) is capable of facilitating the exchange of one silicon-bonded alkyl group of a first silane molecule with a silicon-bonded halogen atom of a second silane molecule.
[0008] The present disclosure further provides a reaction product prepared according to the method.DETAILED DESCRIPTION
[0009] A method of preparing a target compound is disclosed. The target compound is generally an organosilicon compound, and can be referred to as the target organosilicon compound. The target organosilicon compound can be utilized in myriad end use applications and can be selectively prepared via the inventive method in desirable yields.
[0010] The method comprises combining (A) an organosilicon component and (B) a catalyst comprising a boron cluster to give a mixture. The organosilicon component (A) and the catalyst (B) can be combined in any order of addition, optionally via masterbatches, and optionally under shear or mixing.
[0011] The organosilicon component (A) comprises (A1) a first organosilicon compound having at least one silicon-bonded C1-C4 alkyl group and optionally at least one silicon-bonded halogen atom. When the first organosilicon compound (A1) does not include a silicon-bonded halogen atom, the organosilicon component (A) further comprises a second organosilicon compound (A2) including at least one silicon-bonded halogen atom. The halogen atom is fluorine (F), chlorine (Cl), bromine (Br), or iodine (I). In certain embodiments, the halogen atom is fluorine (F), chlorine (Cl), or bromine (Br). In specific embodiments, the halogen atom is Cl. Examples of suitable C1-C4 alkyl groups include methyl, ethyl, propyl (e.g. iso-propyl and / or n-propyl), and butyl (e.g. isobutyl, n-butyl, tert-butyl, and / or sec-butyl). In certain embodiments, the C1-C4 alkyl groups are not branched. In specific embodiments, the C1-C4 alkyl groups are independently methyl, ethyl, or propyl, alternatively methyl or ethyl, alternatively methyl.
[0012] Thus, in the organosilicon component (A), there is at least one silicon-bonded C1-C4 alkyl group and at least one silicon-bonded halogen atom, which may be present in the same or different molecules, as described below. For example, the organosilicon component (A) generally includes a plurality of molecules. The first organosilicon compound (A1) of the organosilicon component (A) may include different species of organosilicon compounds having at least one silicon-bonded C1-C4 alkyl group and optionally at least one silicon-bonded halogen atom. When the molecules of the first organosilicon compound (A1) do not include any silicon-bonded halogen atoms, then the organosilicon component (A) further comprises the second organosilicon compound (A2) which includes at least one silicon-bonded halogen atom. Like the first organosilicon compound (A1), the second organosilicon compound (A2) of the organosilicon component (A) may include different species of organosilicon compounds having at least one silicon-bonded halogen atom.
[0013] Typically, the first organosilicon compound (A1) and the second organosilicon compound (A2), if utilized, are monosilanes, i.e., include one silicon atom. More specifically, the first organosilicon compound (A1) and the second organosilicon compound (A2), if utilized, are typically free from siloxane bonds (-Si-O-Si-) or silicon-silicon bonds (-Si-Si-).
[0014] In certain embodiments, the first organosilicon compound (A1) is free from any silicon-bonded groups or atoms other than C1-C4 alkyl groups and halogen atoms. In such embodiments, the first organosilicon compound (A1) is free from, for example, silicon-bonded hydrogen atoms. In further embodiments, the organosilicon component (A) is free from organosilicon compounds having any silicon-bonded groups or atoms other than C1-C4 alkyl groups and halogen atoms, i.e., in such embodiments, if the organosilicon component (A) further comprises the second organosilicon compound (A2), the second organosilicon compound (A2) is also free from, for example, silicon-bonded hydrogen atoms.
[0015] In one embodiment, the first organosilicon compound (A1) includes both a silicon-bonded C1-C4 alkyl group and at least one silicon-bonded halogen atom. In some such embodiments, the first organosilicon compound (A1) has the general formula RxHyQzSi, where each R is an independently selected alkyl group having from 1 to 4 carbon atoms, each Q is an independently selected halogen atom, 1≤x≤4, alternatively 1≤x≤3, 0≤y≤2, 1≤z≤3 and x+y+z=4. Examples of halogen atoms and C1-C4 alkyl groups are described above.
[0016] In specific embodiments, subscript y is 0 such that the first organosilicon compound (A1) has the general formula RxQzSi, where1≤x≤3, 1≤z≤3 and x+z=4. For example, when x is 1, z is 3, R is Me, and Q is Cl, the first organosilicon compound has formula MeSiCl3. When x is 2, z is 2, R is Me, and Q is Cl, the first organosilicon compound has formula Me2SiCl2.
[0017] The first organosilicon compound (A1) can include two or more different organosilicon compounds that differ in structure. By way of example, the first organosilicon compound (A1) can comprise a mixture of MeSiCl3 and Me2SiCl2.
[0018] In other embodiments, as described above, the first organosilicon compound (A1) can be free of silicon-bonded halogen atoms. In such embodiments, the first organosilicon compound can have the formula R4Si, where each R is independently selected and defined above.
[0019] When the first organosilicon compound (A1) is free of silicon-bonded halogen atoms, the organosilicon component (A) further comprises the second organosilicon compound (A2). The second organosilicon compound (A2) includes at least one silicon-bonded halogen atom, but is not otherwise limited. Typically, any silicon-bonded groups or atoms in the second organosilicon compound (A2) that are not silicon-bonded halogen atoms are silicon-bonded C1-C4 alkyl groups, as described above for the first organosilicon compound (A1). For example, the second organosilicon compound (A2) can include one silicon-bonded halogen atom and three silicon-bonded C1-C4 alkyl groups, two silicon-bonded halogen atoms and two silicon-bonded C1-C4 alkyl groups, three silicon-bonded halogen atoms and one silicon-bonded C1-C4 alkyl group, or four silicon-bonded halogen atoms. The halogen atoms and C1-C4 alkyl groups are independently selected. The second organosilicon compound (A2) can include two or more different organosilicon compounds that differ in structure. By way of example, the second organosilicon compound (A2) can comprise a mixture of MeSiCl3 and Me2SiCl2.
[0020] Although both the first and second organosilicon compounds (A1), (A2), can each independently comprise blends of different organosilicon compounds that differ from one another in structure, the first organosilicon compound (A1) is different from and does not encompass the same species of molecules as the second organosilicon compound (A2). For example, although it is described above that either the first organosilicon compound (A1) or the second organosilicon compound (A2) can comprise a mixture of MeSiCl3 and Me2SiCl2, the first and second organosilicon compounds (A1), (A2) do not simultaneously comprise or include the same molecules or compounds. If the second organosilicon compound (A2) is a mixture of MeSiCl3 and Me2SiCl2, it's typically because the first organosilicon compound (A1) is free of silicon-bonded halogen atoms, e.g. is R4Si such that the first and second organosilicon compounds (A1), (A2) remain different from one another.
[0021] In certain embodiments, the first organosilicon compound (A1) comprises R4Si, RSiQ3 or R2SiQ2, where each R and each Q is independently selected and defined above. When the first organosilicon compound (A1) comprises R4Si, the organosilicon component further comprises the second organosilicon compound (A2). In such embodiment, the second organosilicon compound (A2) can be or comprises RSiQ3, R2SiQ2, or SiQ4, where each R and each Q is independently selected and defined above.
[0022] In one embodiment, the first organosilicon compound (A1) comprises, consists essentially of, or consists of RSiQ3, e.g. MeSiCl3, where Me indicates methyl.
[0023] In another embodiment, the first organosilicon compound (A1) comprises, consists essentially of, or consists of R2SiQ2, e.g. Me2SiCl2, where Me indicates methyl.
[0024] In yet another embodiment, the first organosilicon compound (A1) comprises RSiQ3, e.g. MeSiCl3, where Me indicates methyl, and wherein the organosilicon component (A) further comprises the second organosilicon compound (A2). The second organosilicon compound (A2) in such embodiments may be, for example, R2SiQ2, e.g. Me2SiCl2. As understood in the art, in embodiments in which the organosilicon component comprises both RSiQ3 and R2SiQ2, it can be considered that the first organosilicon compound (A1) comprises a mixture of RSiQ3 and R2SiQ2, as each molecule includes a silicon-bonded C1-C4 alkyl group and a silicon-bonded halogen atom. Alternatively, in such embodiments, it can be considered that the first organosilicon compound (A1) comprises RSiQ3 and the second organosilicon compound (A2) comprises R2SiQ2.
[0025] In yet another embodiment, the first organosilicon compound (A1) comprises R4Si, e.g. Me4Si, where Me indicates methyl, and wherein the organosilicon component (A) further comprises the second organosilicon compound (A2). The second organosilicon compound (A2) in such embodiments may be, for example, RSiQ3, e.g. MeSiCl3.
[0026] In other embodiments, the first organosilicon compound (A1) comprises RSiQ3, e.g. MeSiCl3, where Me indicates methyl, and wherein the organosilicon component (A) further comprises the second organosilicon compound (A2). The second organosilicon compound (A2) in such embodiments may be, for example, R3SiQ, e.g. Me3SiCl. As understood in the art, in embodiments in which the organosilicon component comprises both RSiQ3 and R3SiQ, it can be considered that the first organosilicon compound (A1) comprises a mixture of RSiQ3 and R3SiQ, as each molecule includes a silicon-bonded C1-C4 alkyl group and a silicon-bonded halogen atom. Alternatively, in such embodiments, it can be considered that the first organosilicon compound (A1) comprises RSiQ3 and the second organosilicon compound (A2) comprises R3SiQ.
[0027] When the organosilicon component (A) includes both the first and second organosilicon compounds (A1), (A2), the first and second organosilicon compounds (A1), (A2) may be utilized in various amounts or ratios, which can be influenced by myriad factors, including the desired structure of the target organosilicon compound.
[0028] In certain embodiments, the second organosilicon compound (A2) is utilized in a molar excess relative to the first organosilicon compound (A1). For example, the second organosilicon compound (A2) can be used in a molar ratio of from greater than 1:1 to 100:1, alternatively from greater than 1:1 to 80:1, alternatively from greater than 1:1 to 60:1, alternatively from greater than 1:1 to 40:1, alternatively from greater than 1:1 to 20:1, alternatively from greater than 1:1 to 10:1, relative to the first organosilicon compound (A1). In other embodiments, however, the second organosilicon compound (A2) is utilized in a molar excess relative to the first organosilicon compound (A1). In such embodiments, the molar ratios above apply in inverted form, i.e., the ratios above apply as the ratio of the first organosilicon compounds (A1) to the second organosilicon compound (A2). Alternatively still, stoichiometric ratios can be utilized.
[0029] The catalyst (B) comprises a boron cluster and is capable of facilitating the exchange of one silicon-bonded alkyl group of a first silane molecule with a silicon-bonded halogen atom of a second silane molecule. The catalyst (B) is not limited so long as the catalyst comprises the boron cluster and is capable of facilitating the exchange of one silicon-bonded alkyl group of a first silane molecule with a silicon-bonded halogen atom of a second silane molecule. In addition, as introduced above, the boron cluster comprises a plurality of boron atoms and one carbon atom. The catalyst (B) may be formed in situ in the presence of the organosilicon component (A). For example, the composition may utilize a pre-catalyst, which converts to a catalytically active form in situ to give the catalyst (B). In such embodiments, the pre-catalyst may be any suitable pre-catalyst that forms the catalytically active form of the catalyst (B) in situ.
[0030] In certain embodiments, the catalyst (B) comprises a salt comprising one monoanion having a charge of -1 and one cation, wherein the one monoanion comprises the boron cluster.
[0031] In specific embodiments, the one monoanion has the formula (CBaXp), where subscript a is 9 or 11, subscripts b=(a+1), wherein each X is independently selected from -SiR13 groups, where each R1 is independently a hydrocarbyl group, a halogen atom or H; halogen atoms; H; hydrocarbyl groups; and OR2 groups, where each R2 is independently H, an alkyl group, or a silyl group.
[0032] The halogen atoms that may be represented by X can be fluorine (F), chlorine (Cl), bromine (Br), iodine (I). In certain embodiments, when X is a halogen atom, the halogen atom is Br, Cl, or F. In yet other embodiments, when X is a halogen atom, the halogen atom is Cl or Br. In specific embodiments, when X is a halogen atom, the halogen atom is Cl.
[0033] In one specific embodiment, at least one X is an -SiR13 groups, where each R1 is independently an alkyl group or a halogen atom. When each R1 is methyl, the -SiR1, 3 group is a trimethylsilyl group. When two of R1 are methyl and the other is chlorine, the -SiR1 3 group is a dimethylchlorosilyl group. When all of R1 are chlorine, the -SiR1 -SiR13 group is a trichlorosilyl group.
[0034] In one embodiment, at least one X is an -OR2 group, where R2 is H, i.e., at least one X is an OH group. In other embodiments when at least one X is an -OR2 group, each R2 is an independently selected alkyl group. In such embodiments, each R2 may be linear, branched, cyclic (e.g., cycloalkyl), or combinations thereof. In certain embodiments, each R2 is linear or branched. In specific embodiments, each R2 is linear. In certain embodiments, each R2 independently has from 1 to 8, alternatively from 1 to 7, alternatively from 1 to 6, alternatively from 1 to 5, alternatively from 1 to 4, alternatively from 1 to 3, alternatively from 1 to 2, alternatively 1, carbon atoms.
[0035] In one embodiment, at least one X is an -OR2 group, where R2 is a silyl group. The silyl group is typically an -SiR33 group, where each R3 is independently an alkyl group or a halogen atom, such that X is of formula -OSiR33. In another embodiment, the silyl group represented by R2 includes a siloxane bond such that X is a siloxy moiety. Typically, even when R2 includes a siloxane bond, R2 is linear and free from T or Q siloxy units.
[0036] In one specific embodiment, only one X is a hydrocarbyl group or H. In this specific embodiment, the X that is the hydrocarbyl group or H is bonded to C in the monoanion boron cluster, and the remaining X groups that are bonded to B are other than H or hydrocarbyl groups, i.e., selected from -SiR13 groups, where each R1 is independently a hydrocarbyl group, a halogen atom or H; halogen atoms; and OR2 groups, where each R2 is independently H, an alkyl group, or a silyl group.
[0037] In one embodiment, at least one X is a hydrocarbyl group, which are independently selected when more than one X is a hydrocarbyl group. Suitable hydrocarbyl groups may independently be linear, branched, cyclic, or combinations thereof. Cyclic hydrocarbyl groups encompass aryl groups as well as saturated or non-conjugated cyclic groups. Cyclic hydrocarbyl groups may be monocyclic or polycyclic. Linear and branched hydrocarbyl groups may independently be saturated or unsaturated. One example of a combination of a linear and cyclic hydrocarbyl group is an alkyl substituted aryl group. By "substituted,” it is meant that one or more hydrogen atoms may be replaced with atoms other than hydrogen (e.g. a halogen atom, such as chlorine, fluorine, bromine, etc.) or groups other than hydrogen. Suitable alkyl groups are exemplified by, but not limited to, methyl, ethyl, propyl (e.g. isopropyl and / or n-propyl), butyl (e.g. isobutyl, n-butyl, tert-butyl, and / or sec-butyl), pentyl (e.g. isopentyl, neopentyl, and / or tert-pentyl), hexyl, as well as branched saturated hydrocarbon groups of 6 carbon atoms. Suitable aryl groups are exemplified by, but not limited to, phenyl, tolyl, xylyl, naphthyl, benzyl, and dimethylphenyl. Suitable alkenyl groups include vinyl, allyl, propenyl, isopropenyl, butenyl, isobutenyl, pentenyl, heptenyl, hexenyl, and cyclohexenyl groups. Suitable monovalent halogenated hydrocarbon groups include, but are not limited to, a halogenated aryl group of 6 to 10 carbon atoms. Suitable halogenated aryl groups are exemplified by, but not limited to, the aryl groups described above where one or more hydrogen atoms is replaced with a halogen atom, such as For Cl. For example, chloroaryl and fluoroaryl are suitable halogenated aryl groups.
[0038] In specific embodiments when at least one X is a hydrocarbyl group, the hydrocarbyl group is unsubstituted, and is selected from aliphatic hydrocarbon groups and aromatic hydrocarbyl groups. In more specific embodiments, the hydrocarbyl group is selected from alkyl groups and aryl groups.
[0039] Examples of suitable alkyl groups for X, R1, and R2 include methyl, ethyl, propyl (e.g. isopropyl and / or n-propyl), butyl (e.g., isobutyl, n-butyl, tert-butyl, and / or sec-butyl), pentyl (e.g. isopentyl, neopentyl, and / or tert-pentyl), hexyl, hexadecyl, and octadecyl, as well as branched saturated hydrocarbon groups having from 6 to 8 carbon atoms. Examples of suitable non-conjugated cyclic groups (e.g. cycloalkyl groups) include cyclobutyl, cyclohexyl, and cycloheptyl groups.
[0040] In one embodiment, subscript a is 9 (in which case subscript b is 10). In another embodiment, subscript a is 11 (in which case subscript b is 12). In one embodiment when subscript a is 9, at least one, alternatively at least two, alternatively at least three, alternatively at least four, alternatively at least five, alternatively at least six, alternatively at least seven, alternatively at least eight, alternatively at least nine, alternatively all 10 of X are halogen atoms. In one embodiment when subscript a is 11, at least one, alternatively at least two, alternatively at least three, alternatively at least four, alternatively at least five, alternatively at least six, alternatively at least seven, alternatively at least eight, alternatively at least nine, alternatively at least 10, alternatively at least 11, alternatively all 12 of X are halogen atoms. In yet other embodiments, regardless of whether subscript a is 9 or 11, each X is other than a halogen atom.
[0041] Typically, the cation of the salt of the catalyst is a Brønsted or Lewis acid. In one embodiment, the cation of the catalyst is a Brønsted acid. In another embodiment, the cation of the catalyst is a Lewis acid.
[0042] When the cation comprises a Brønsted acid, the cation may comprise or be a proton (H+), which may optionally be associated with a molecule. For example, in one embodiment, the cation comprises a proton associated with a molecule having the general formula Z-O-Z, where each Z is independently selected from H, a silyl group, and a substituted or unsubstituted hydrocarbyl group, which may also include one or more heteroatoms such as O, N, and / or S.
[0043] Suitable hydrocarbyl groups Z include any of those described above for X, except that each Z may independently include a heteroatom in the chain other than carbon. In such embodiments, Z may be considered a heterocarbyl group. Suitable heterocarbyl groups include any of the hydrocarbyl groups described above, but including one or more heteroatoms, such as oxygen, sulfur, nitrogen, etc. Depending on a selection of Z in such embodiments, the molecule may be a glycol ether or derivative thereof.
[0044] Silyl groups are known in the art and comprise at least one silicon atom. When Z is a silyl group, typically a silicon atom of the silyl group is bonded to oxygen in the molecule. The silyl group may be, for example, a triorganosilyl group, e.g. (CH3)3Si-. Alternatively, the silyl group may comprise more than one silicon atom. For example, the silyl group may be a siloxy group.
[0045] When Z is the silyl group or the substituted or unsubstituted hydrocarbyl group, each Z may be linked together such that the molecule represented by the general formula Z-O-Z is cyclic or a ring structure. As but one example, the molecule represented by the general formula Z-O-Z can be tetrahydrofuran (THF). In such embodiments, each Z can be considered a C2 hydrocarbon moiety linked together (or one Z can be a C1 hydrocarbon moiety and the other Z can be a C3 hydrocarbon moiety linked together, as the total number of carbon atoms linked together in such an embodiment would be four).
[0046] In another embodiment, the cation comprises a proton associated with a hydrocarbon and / or a silane compound. Specific examples of suitable hydrocarbons include those described above for Z, but in the form of hydrocarbon molecules rather than hydrocarbon substituents (i.e., not in monovalent form). By way of example, a hexenyl group described above for Z would be suitable as the hydrocarbon as the molecule as hexene, i.e., not in monovalent form.
[0047] In specific embodiments when the cation is a proton associated with a hydrocarbon, the hydrocarbon comprises at least one unsaturated moiety, which may be aliphatic or aromatic. For example, when the hydrocarbon comprises at least one unsaturated moiety, the hydrocarbon may be an alkene, an alkyne, an arene, etc. In one embodiment, the proton can be associated with an arene to give an arenium cation. Other examples of molecules suitable for association with the proton when the cation comprises the proton include cyclic thioethers, nitriles, ketones, carboxylic acids, esters, amides, and combinations thereof.
[0048] In other embodiments, the cation comprises a Lewis acid.
[0049] For example, in one embodiment, the cation comprises a Lewis acid, and the Lewis acid comprises a silylium cation or a carbocation.
[0050] In specific embodiments when the cation comprises a Lewis acid, and the Lewis acid comprises a silylium cation, the silylium cation has the formula (R4)3Si+, where each R4 is independently selected from H, a substituted or unsubstituted hydrocarbyl group, and a halogen atom. Examples of substituted and unsubstituted hydrocarbyl groups as well as halogen atoms are described above. In specific embodiments, each R4 is an independently selected alkyl group. In other embodiments, at least one R4 is a halogen atom, and the remaining of R4 are alkyl groups. In yet other embodiments, two of R4 are independently selected halogen atoms, and the remaining of R4 is an alkyl group. In further embodiments, each R4 is an independently selected halogen atom.
[0051] In further specific embodiments when the cation comprises a Lewis acid, and the Lewis acid comprises a silylium cation, the silylium cation is associated with a silane compound, a hydrocarbon, a substituted or unsubstituted arene, or a molecule having the general formula Z-O-Z, where each Z is independently selected and defined above. Arenes may optionally be substituted with one or more alkyl groups.
[0052] Specific examples of suitable carbocations include areniums, benzyl, t-butyl, trityl, CH3+, and other tertiary hydrocarbon cations. One specific example of a suitable arenium is benzenium. One of skill in the art readily understands other suitable carbocations based on aromatic and aliphatic hydrocarbons.
[0053] The organosilicon component (A) and / or the catalyst (B) may also be disposed in a vehicle, e.g., a solvent which solubilizes the respective component, alternatively a vehicle which merely carries or disperses, but does not solubilize, the respective component. Such vehicles are known in the art. Alternatively, the organosilicon component (A) and / or the catalyst (B) may be combined neat. Further still, the organosilicon component (A) and the catalyst (B) may also be utilized neat but then may be combined with other components, e.g., a vehicle or solvent, when preparing the organosilicon compound with components (A) and (B).
[0054] Suitable vehicles include organic oils, organic solvents and mixtures thereof.
[0055] Alternatively, the vehicle may comprise an organic solvent. Examples of organic solvents include: aromatic hydrocarbons, such as benzene, toluene, xylene, mesitylene, etc.; aliphatic hydrocarbons, such as heptane, hexane, octane, etc.; and other organic compounds that present as liquid / fluid at typical reaction temperatures, such as, white spirits, mineral spirits, naphtha, and the like, as well as derivatives, modifications, and combinations thereof.
[0056] The vehicle, if utilized, is different from components (A) and (B).
[0057] As introduced above, in various embodiments, the method comprises combining the organosilicon component (A) and a pre-catalyst (B1) different from the catalyst (B), and wherein the catalyst (B) is formed in situ in the presence of the organosilicon component (A) and the arene compound.
[0058] Exemplary examples of the pre-catalyst (B1) include [Et3Si][HCB11Cl6H5], [Et3Si][HCB11Br6H5], [Et3Si][1-Me-CB11Cl6H5], [Et3Si][HCB11H11], [H][HCB11Cl6H5]·2(H2O), [H][HCB11Br6H5]·2(H2O), [H][1-Me-CB11Cl6H5]·2(H2O), [H][HCB11H11]·2H2O, and combinations thereof. One of skill in the art readily appreciates how, in any of the exemplary examples above, any chlorine atom may be replaced with another halogen atom, and different combinations are contemplated in view of the selections of X described above, and subscripts a and b in the catalyst (B) and corresponding pre-catalyst (B1).
[0059] The exemplary examples of the pre-catalyst (B1) above include both hydrated (or "wet") and non-hydrated (or "dry") species. As described below, the number of water molecules shown is representative and may vary. It is to be appreciated that the term "hydrated" or "wet" is not limited only to H2O, as alcohols and ethers (depending on the selection of each Z in ZOZ) may also be present in the pre-catalyst (C1) in combination with or in lieu of water. In view of the description above, one of skill in the art understands how water can be replaced with other ZOZ molecules, such as alcohols or, for example, THF (when each Z is a hydrocarbyl group linked together to form a ring structure).
[0060] Other examples of the pre-catalyst (B1) include, for example, [Et3Si][HCB11F11], [Et3Si][MeCB11F11], [Et3Si][HCB11H5Cl6], [Et3Si][HCB11Cl11], [Et3Si] [MeCB11CI11], [Et3Si][HCB11H5Br6], [Et3Si] [HCB11Br11], [Et3Si] [MeCB11Br11], [Et3Si][HCB11H516], [Et3Si][HCB11 / 11], [Et3Si] [MeCB11 / 11], [Et3Si][HCB11Cl6Br5], [Et3Si][HCB11Cl5Br6], [Et3Si][HCB11C1615], [Et3Si][HCB11Br5|6], [Et3Si][HCB11Br615], [Et3Si][HCB11Me6H5], [Et3Si][HCB11Et6H5], [Et3Si][HCB11Me6Et5], [Et3Si][MeCB11Me11], [Et3Si][HCB11Cl6Me5], [Et3Si][HCB11Br6Me5], [Et3Si] [HCB1116Me5], [Et3Si][HCB11FH10], [Et3Si][HCB11CIH10], [Et3Si][HCB11CIH9], [Et3Si][HCB11BrH10], [Et3Si][HCB11Br2H9], [Et3Si] [HCB11CIFHg], [Et3Si][HCB11BrFH]9, [Et3Si][HCB11|FH9], [Et3Si][HCB11I(OH)Hg, [Et3Si][YCB11Me10] (Y = H, alkyl), [Et3Si][MeCB11Me10(OY1)] (Y1 = alkyl), [Et3Si][HCB9C15H4], [Et3Si][HCB9C19], [Et3Si][HCB9Br5H4], [Et3Si][HCBgBrg], [Et3Si][HCB9l9, [Et3Si][HCB9Meg], [Et3Si][HCB9CIH8], [Et3Si][HCBgCl2H7], [Et3Si][HCBgBrH8], [Et3Si][HCBgBr2H7], [Et3Si][HCBglH8], and [Et3Si][HCB92H7]. One of skill in the art readily appreciates other species of pre-catalysts (B1) in view of the description herein, including by replacement of the cation [Et3Si] with other cations, or replacement of each X with other X groups, as described above.
[0061] In specific embodiments, the pre-catalyst (B1) comprises the hydronium salt of a boron cluster (a monoanionic boron cluster). As described above, as one exemplary example, the counterion to the monoanionic boron cluster can simply be one proton (H+). The boron cluster is extremely stable, and non-coordinating. Because the boron cluster is substantially non-coordinating, the associated proton or counterion is strongly acidic. Because the proton or counterion is strongly acidic, the proton will interact very strongly with ZOZ molecules. Typically, the pre-catalyst (B1) in wet form cannot be completely dried to become free of ZOZ molecules (like water) by traditional means (e.g. heating under vacuum). Generally, even after drying excess water under vacuum, from two to six or more ZOZ molecules may remain associated with the boron cluster.
[0062] In the method of the subject disclosure, either the wet (including ZOZ molecules) or the dry (free from ZOZ molecules) versions of the pre-catalyst (B1) may be utilized. As described below, the number of ZOZ molecules shown is representative and may vary. The hydrated forms of the pre-catalyst (C1) can be converted to the dry or non-hydrated forms via the methods described herein and in co-pending U.S. application number 63 / 769,743 filed herewith, which is incorporated by reference herein. Further still, the catalyst (B) can be formed in situ, or synthesized prior to use, from other routes not reliant on the pre-catalyst (B1). In specific embodiments, the pre-catalyst (B1) is free of ZOZ molecules.
[0063] By way of example, because the cation, e.g., the proton, associated with the boron cluster is strongly acidic, the proton may react with a hydridic Si-H bond. The boron cluster will "dry" in-situ through reaction of the Si-H material with the acidic water, forming a by-product disiloxane. More specifically, the proton may react with a hydridic Si-H bond to make silylium cation and H2. Two silylium cations can then react with ZOZ to form a disiloxane, regenerating two protons. As the ZOZ molecules are subsequently removed, the proton becomes less stabilized by the coordination of ZOZ molecules and thus becomes more acidic and thus more reactive. This reaction cascade continues until all the protons are reacted and the silylium cation remains as counterion. Alternatively or in addition, the boron cluster can by "dried” in situ via a reaction with a chlorosilane, where silylium and HCl gas are prepared by drying rather than silylium and H2 gas.
[0064] As such, the hydrated or acidic form of the boron cluster can be converted to a silylium salt. In both the hydrated and silylium salt structures, the counterion is at most only very weakly coordinated to the boron cluster and these compounds should be seen as mostly ionic.
[0065] The catalyst (B), whether used discretely or formed in situ, comprises a halosilylium, typically a chlorosilylium. The halosilylium is cationic and associated with the boron cluster, which is anionic and is the counterion.
[0066] Boron clusters are extremely stable. In addition, boron clusters are substantially weak- or non-coordinating, thus they do not significantly quench the Lewis acidity of the silylium cation. This key combination of a highly Lewis acidic "free" silylium cation and a highly stable anionic boron cluster is what makes catalytic activity of the catalyst (B) possible.
[0067] The catalyst (B) (or the pre-catalyst (B1)) is utilized in a catalytic amount. The catalytic amount can be readily determined by one of skill in the art. In certain embodiments, the catalytic amount of the catalyst (B) (or the pre-catalyst (B1)) is from greater than 0 to 10, alternatively from greater than 0 to 9, alternatively from greater than 0 to 8, alternatively from greater than 0 to 7, alternatively from greater than 0 to 6, alternatively from greater than 0 to 5, alternatively from greater than 0 to 4, alternatively from greater than 0 to 3, alternatively from greater than 0 to 2, alternatively from greater than 0 to 1, alternatively from greater than 0 to 0.9, alternatively from greater than 0 to 0.8, alternatively from greater than 0 to 0.7, alternatively from greater than 0 to 0.6, alternatively from 0 to 0.5, weight percent based on the total weight of the organosilicon component (A).
[0068] The target organosilicon compound is prepared via alkyl or halogen atom exchange. The reaction is typically carried out at an elevated temperature that is greater than room temperature. In other embodiments, the reaction is carried out at room temperature. In certain embodiments, the elevated temperature is from greater than room temperature to 250, alternatively from greater than room temperature to 250, alternatively from greater than room temperature to 225, alternatively from 100 to 220, °C. In these or other embodiments, the reaction is carried out an elevated pressure greater than atmospheric pressure. In certain embodiments, the elevated pressure is from greater than atmospheric pressure to 5,000 kPa. The elevated pressure may be a function of gas generation from the reaction in a sealed reactor, vapor pressures of the reactants, intermediates, and products, the presence or absence of any optional vehicles, and / or inert gas pressure., etc.
[0069] The structure of the target organosilicon compound formed via the method is a function of the particular organosilicon component (A) utilized, including the species of the first organosilicon compound (A1) and the presence (and selection) or absence of the second organosilicon compound (A2). The target organosilicon compound is different from the compounds of the organosilicon component (A), including the first and second organosilicon compounds (A1), (A2).
[0070] In certain embodiments, the target compound has the general formula Rx'Hy'Q4-x'-y'Si, where each R is an independently selected alkyl group having from 1 to 4 carbon atoms, each Q is an independently selected halogen atom, 1≤x≤3, 0≤y'≤2, and x'+y' is from 1 to 4, with the proviso that the target compound is different from the first organosilicon compound (A1) and, if utilized, the second organosilicon compound (A2).
[0071] The target organosilicon compound is typically prepared in a reaction product. The reaction product may include the target organosilicon compound and other species of organosilicon compounds. For example, it is possible that there could be rearrangement of other silicon-bonded groups in certain byproducts produced along with the organosilicon compound, which are not the target species. These certain byproducts may be utilized for other purposes, recycled, etc. In fact, certain byproducts may be other than organosilicon compounds and instead be halosilanes, e.g. SiCl4. When byproducts other than organosilicon compounds are prepared via the method, the reaction product still includes organosilicon compounds. However, these other byproducts can also be desirable and advantageously prepared for their other end use applications.
[0072] In certain embodiments, the target organosilicon compound is free from silicon-bonded hydrogen atoms. In such embodiments, the target compound may have the general formula Rx'Q4-x'Si, where each R is an independently selected alkyl group having from 1 to 4 carbon atoms, each Q is an independently selected halogen atom, and 1≤x≤3, with the proviso that the target compound is different from the first organosilicon compound (A1) and, if utilized, the second organosilicon compound (A2).
[0073] In certain embodiments, the method further comprises isolating the organosilicon compound from the reaction product.EXAMPLES
[0074] The following examples, illustrating embodiments of this disclosure, are intended to illustrate and not to limit the invention. Unless otherwise noted, all reactions are carried out under air, and all solvents, substrates, and reagents are purchased or otherwise obtained from various commercial suppliers (e.g., Strem Chemicals, Acros Organics, Sigma-Aldrich, etc.) and utilized as received.
[0075] A brief summary was provided in Table 1 below, setting forth information as to certain abbreviations, shorthand notations, and components utilized in the Examples, as well as their sources. In the Tables below, "C." prior to identification of each Component (B) indicates a Comparative Component (B). As used herein, "Bu” indicates butyl; "n-Bu" indicates normal-butyl; "Et" indicates methyl; "Me" indicates methyl; "h" indicates hour(s); and "Ph" indicates phenyl.
[0076] In each of the Examples, the catalyst is prepared in situ from a pre-catalyst. Thus, each component (B) is referred to below as a Pre-Catalyst, with the corresponding catalyst being prepared in situ in each Practical Example.
[0077] In certain components below, water molecules are present. As described above, the number of water molecules shown is representative and may vary.
[0078] Table 1: Materials Utilized and SourcesComponent | Description---|---(B1) | [H][HCB11CI6H5]·2(H2O), as prepared in Synthesis Example 1(B2) | [Et3Si][HCB11Cl6H5], as prepared in Synthesis Example 2(B3) | [H][HCB11Br6H5]·2(H2O), as prepared in Synthesis Example 3(B4) | [Et3Si][HCB11Br6H5], as prepared in Synthesis Example 4(B5) | [H][MeCB11Cl6H5]·2(H2O) as prepared in Synthesis Example 5(B6) | [Et3Si] [MeCB11Cl6H5] as prepared in Synthesis Example 6(B7) | [H][HCB11H11].2H2O as prepared in Synthesis Example 7(B8) | [Et3Si][HCB11H11] as prepared in Synthesis Example 8C.(B1) | Cs2[B12Cl12], as prepared in Synthesis Example 9C.(B2) | Et3SiOTf (triethylsilyl trifluoromethanesulfonate), Sigma-AldrichC.(B3) | [Et3NH]2[B12Cl12], as isolated as an intermediate in Synthesis Example 9Cs2[B12H12] | Strem ChemicalsNa2[B10H10] | Boron Specialties LLCCs[HCB11H11] | Strem Chemicals(H)2[B12F12], 48–52 wt% solution in water | Boron Specialties LLCTrichloroisocyanuric acid | Acros OrganicsCesium Chloride | Sigma-AldrichTriethylammonium chloride | Sigma-AldrichSodium hydroxide solution (50 wt%) | Fisher Chemical(H+) ion exchange resin | divinylbenzene-styrenesulfonic acid copolymer (CAS: 39389-20-3), Sigma-AldrichChloroform | Sigma-AldrichSodium bromide | Sigma-AldrichSodium sulfite | Sigma-AldrichAluminum chloride (anhydrous) | Sigma-AldrichDiethyl ether | Fisher ChemicalHydrochloric acid (37%) | Fisher ChemicalMethyldichlorosilane | Sigma-AldrichTrichlorosilane | Sigma-AldrichDimethylchlorosilane | Sigma-AldrichTriethylsilane | Sigma-AldrichBenzene-d6 | Sigma-AldrichCyclohexane (internal standard) | Sigma-AldrichHexane | Sigma-AldrichHeptane | Sigma-AldrichToluene | Sigma-AldrichBenzene | Sigma-AldrichTetrachlorosilane | Sigma-AldrichMethyltrichlorosilane | Sigma-AldrichDimethyldichlorosilane | Sigma-AldrichTrimethylchlorosilane | Sigma-AldrichSynthesis Examples
[0079] Synthesis Example 1: [H][HCB11CI6H5]·2(H20)
[0080] A solution of Cs[HCB11H11] in acetic acid was treated with a molar excess of trichloroisocyanuric acid at 110 °C to prepare a reaction mixture. The reaction mixture was treated with [Et3NH]Cl to isolate [Et3NH][HCB11Cl6H5] from the reaction mixture. A solution of [Et3NH][HCB11Cl6H5] in ethanol was treated with (H+) ion exchange resin and concentrated under vacuum to give a residue. The residue was dissolved in water to give a solution, and the solution was treated with (H+) ion exchange resin and concentrated under vacuum to prepare [H][HCB11CI6H5]·2(H2O).
[0081] Synthesis Example 2: [Et3Si][HCB11CI6H5]
[0082] In an argon-purged glovebox, Et3SiH (338 mg) was added to [H][HCB11CI6H5]·2(H2O) (100 mg) in benzene (2 mL) in a reaction vessel to give a reaction mixture. The reaction vessel was left open, and bubbling, which was immediately observed, continued for about 5 minutes. The reaction mixture was left standing at room temperature for 30 minutes. An oil appeared to form, which then solidified as a brown solid. The reaction mixture was heated to 100 °C for 1 h, after which time gas evolution had fully subsided, resulting in a residue. The residue was removed from the reaction mixture, and the residue was rinsed first with toluene (2 mL), and then with heptane (2 mL). The residue was dried in vacuo, yielding [Et3Si][HCB11Cl6H5] as a brown solid (95 mg). Successful preparation of [Et3Si][HCB11Cl6H5] was confirmed by NMR analysis in a 50:50 C6D6 0-difluorobenzene mixture.
[0083] Synthesis Example 3: [H][HCB11Br6H5]·2(H2O)
[0084] A solution of Cs [HCB11H11] in acetic acid was prepared and treated with a molar excess of trichloroisocyanuric acid and a molar excess of sodium bromide at 110 °C to give a reaction mixture. The reaction mixture was treated with [Et3NH]Cl to isolate [Et3NH][HCB11Br6H5]. A solution of [Et3NH][HCB11Br6H5] in methanol was treated with (H+) ion exchange resin and concentrated under vacuum to give a residue. The residue was dissolved in water to give a solution, and the solution was treated with (H+) ion exchange resin and concentrated under vacuum to prepare [H][HCB11Br6H5]·2(H20).
[0085] Synthesis Example 4: [Et3Si][HCB11Br6H5]
[0086] In an argon-purged glovebox, Et3SiH (338 mg) was added to [H][HCB11Br6H5]·2(H2O) (125 mg) in benzene (2 mL) in a reaction vessel to give a reaction mixture. The reaction vessel was left open, and bubbling, which was immediately observed, continued for about 5 minutes. The reaction mixture was left standing at room temperature for 30 minutes. An oil appeared to form, which then solidified as a brown solid. The reaction mixture was heated to 100 °C for 1 h, after which time gas evolution had fully subsided, resulting in a residue. The residue was removed from the reaction mixture, and the residue was rinsed first with toluene (2 mL), and then with heptane (2 mL). The residue was dried in vacuo, yielding [Et3Si][HCB11Br6H5] as a brown solid (95 mg). Successful preparation of [Et3Si][HCB11Br6H5] was confirmed by NMR analysis in a 50:50 C6D6 0-difluorobenzene mixture.
[0087] Synthesis Example 5: [H][1-Me-CB11Cl6H5]·2(H2O)
[0088] In a dry nitrogen-purged glovebox (02 < 1 ppm). A stirring solution of Cs[HCB11H11] (872 mg, 3.16 mmol) in tetrahydrofuran (24 mL) was prepared in a 40 mL vial at -20 °C. A solution of n-BuLi in hexanes (4 mL, 1.6 M, 6.4 mmol) was added to the stirring solution over 2 minutes via syringe to yield a suspension. The suspension was allowed to warm to ambient temperature and stirred for 1 h. The suspension was cooled to -20 °C, and Mel (500 μL, 1140 mg, 8.03 mmol) was added to the suspension over ca. 1 minute via syringe. The suspension was allowed to warm to ambient temperature and stirred for 4 hours.
[0089] The vial containing the suspension was removed from the glove box. The suspension was added to deionized water (0.25 mL) in a 100 mL round bottom flask to give a mixture. The mixture was concentrated using a rotary evaporator at 40 °C to give a viscous yellow paste. The paste was extracted with five portions of diethyl ether (5 × 20 mL) to give ether extracts. The combined ether extracts were washed with two portions of aqueous CsCl (20 wt%, 2 x 10 mL). Residue that remained from the extraction was dissolved in the combined CsCl solution from the washing steps to give a solution. This solution was extracted with two portions of diethyl ether (2 × 20 mL). The combined ether extracts were concentrated using a rotary evaporator and then under high vacuum at ambient temperature to give a pale-yellow solid.
[0090] The solid was taken up in acetone (20 mL) and the solution was filtered to yield a filtrate. The filtrate was concentrated using a rotary evaporator and then co-evaporated with deionized water (2 mL) to give a pale-yellow solid. This solid was recrystallized from 5 mL of boiling deionized water to give a white crystalline solid. The white crystalline solid was dried under high vacuum at 50 °C. NMR spectra were consistent with Cs[1-Me-CB11H11] (599 mg, 2.07 mmol, 65%).
[0091] A stirred solution of Cs[1-MeCB11H11] (303.0 mg, 1.045 mmol) in acetic acid (12 mL) in a 40 mL vial fitted with a pressure relief septum cap was prepared. Trichloroisocyanuric acid (243 mg, 1.045 mmol) was added to the stirred solution. The stirred solution was stirred at 110 °C for 3 hours and then allowed to cool to ambient temperature. A further portion of trichloroisocyanuric acid was added (243 mg, 1.045 mmol) and the stirred solution was stirred at 110 °C for 3 hours and then allowed to cool to ambient temperature. A further portion of trichloroisocyanuric acid was added (243 mg, 1.045 mmol) and the stirred solution was stirred at 110 °C for 4 hours and then allowed to cool to ambient temperature to give a reaction mixture. MS data was consistent with the formation of the [1-Me-CB11Cl6H5] anion.
[0092] The reaction mixture was diluted with deionized water (40 mL) and filtered. The filtrate was then combined with the filtrate from an essentially identical reaction. To the combined filtrates was added a solution of [Et3NH]CI (355 mg, 2.58 mmol) in Dl water (10 mL) to give a suspension. A white solid precipitated. The suspension was filtered through a disposable frit. The retentate was washed with several portions of deionized water. The retentate was washed through the frit with acetone. The acetone washings were concentrated using a rotary evaporator and then dried under high vacuum to give a white crystalline solid. NMR spectra were consistent with [Et3NH][1-Me-CB11CI6H5] (700 mg, 1.50 mmol, 87% yield).
[0093] (H+) ion exchange resin (5 g) was washed with several portions of MeOH (5 x 10 mL) to give a washed resin. To the washed resin was added a solution of [Et3NH][1-Me-CB11CI6H5] (500 mg, 1.07 mmol) in MeOH (10 mL) to give a mixture. The mixture was left to stand for 18 hours with occasional swirling. The mixture was filtered to give a clear filtrate. The clear filtrate was concentrated at 40 °C using a rotary evaporator to give a brown oil. The brown oil was taken up in deionized water (20 mL) to give a turbid solution.
[0094] (H+) ion exchange resin (5 g) was washed with several portions of deionized water (3 x 10 mL) to give a washed resin. To the washed resin was added the turbid solution. The mixture was left to stand for 18 hours with occasional swirling. The mixture was filtered, and the filtrate was passed through a 0.45 µm glass microfiber membrane. The filtrate was concentrated using a rotary evaporator at 50 °C and then under high vacuum at 50 °C to give a semi-crystalline brown solid. NMR spectra of the semi-crystalline brown solid were consistent with [H][1-Me-CB11CI6H5]-2(H2O)
[0095] Synthesis Example 6: [Et3Si][1-Me-CB11CI6H5]
[0096] In an argon-filled glovebox, Et3SiH (280 mg) was added at once to [H][1-Me-CB11CI6H5]-2(H2O) (122 mg) in a 20 mL scintillation vial to give a reaction solution, which led to vigorous bubbling. Benzene (1 mL) was rapidly added. Vigorous bubbling was observed, and the solid was observed to turn into a dark brown oil. After about 5 minutes, bubbling had mostly subsided. The reaction solution was left standing at room temperature for 24 h. Heptane (2 mL) was added at once, and the solution was shaken vigorously, causing immediate precipitation of a tan solid residue. The residue was removed and placed in a separate vial, and the residue was dried in vacuo yielding 141 mg of [Et3Si][1-Me-CB11Cl6H5] as a tan solid. The residue (as solids) (15 mg) were dissolved in warm (50 °C) benzene to give a solution, and the solution was left to cool down to room temperature naturally and then analyzed by NMR spectroscopy, confirming formation of [Et3Si][1-Me-CB11Cl6H5]. The solution was left standing at room temperature, resulting in the growth of single crystals which were analyzed by X-ray diffraction, further confirming the formation of the target compound.
[0097] Synthesis Example 7: [H][HCB11H11]·2H2O
[0098] Cs[HCB11H11] (462mg, 1.67 mmol) was charged to a vial under air with ~15mL H2O. The solid slowly dissolved to give a very faint clear yellow solution. Then (H+) ion exchange resin, which was washed 3x with deionized water prior to use, was added and the solution was allowed to stand at ambient temperature for 15 h. The solution was then filtered through a 0.2 µm PTFE syringe filter and the solution was exposed to a stream of nitrogen for an additional 15 hours to slowly remove the water by evaporation. Upon reduction of volume, a viscous liquid was formed, which was then dried at room temperature under high vacuum for an additional 3 h. The resulting viscous brownish material was used without further purification.
[0099] Synthesis Example 8: [Et3Si][HCB11H11]
[00100] To [H] [HCB11H11].2H2O (100 mg) dissolved in benzene (0.6 mL) is added dropwise Et3SiH (460 mg). After addition of each drop of silane, vigorous gas evolution is noted until all acidic protons have reacted. The reaction mixture is left standing at room temperature for 1h, then heptane (4 mL) is added and the solution left standing overnight. The supernatant is transferred to another vial, and toluene (2 mL) is added and the solution is concentrated under vacuum to a volume of ≈ 0.6 mL. Heptane (2 mL) is added to the colorless solution, causing the precipitation of a white solid. The supernatant is removed, the solids are washed with heptane (2 x 2 mL), and the solids are dried in vacuo yielding 80 mg of a white solid. After standing at room temperature for 72h, X-ray quality single crystals form from the supernatant solution. X-Ray diffraction analysis further confirmed formation of the target compound.
[00101] Synthesis Example 9: Cs2[B12CI12]
[00102] In a well-ventilated fume hood, to a 500 mL round-bottom flask was added Cs2[B12H12] (4 g, 9.8 mmol) and deionized (DI) water (200 mL) to give a mixture. The flask was fitted with a water-cooled condenser. The top of the condenser was open to the atmosphere. The mixture was heated to 70 °C with stirring (magnetic stirrer). At this temperature, the solution was colorless and homogeneous. To the mixture was added trichloroisocyanuric acid (18.24 g, 78.5 mmol) in four portions over 48 h. During the reaction, a white crystalline solid precipitated. The progress of the reaction was monitored via 11B NMR spectroscopy. When the reaction was complete, the suspension was allowed to cool to ambient temperature and left to stand for 18 h. The suspension was filtered through a disposable glass frit into a 250 mL round-bottom flask. To the stirring filtrate was added a solution of triethylamine hydrochloride (5.41 g, 39.3 mmol) in water (10 mL). This resulted in the immediate precipitation of a copious quantity of white solid. The suspension was filtered through a disposable glass frit and the filter cake was washed on the frit with DI water. The retentate was dried under vacuum at 50 °C. 1H, 13C, and 11B NMR spectroscopy confirmed the identity of the isolated white solid as [Et3NH]2[B12Cl12] (6.85 g, 9.0 mmol, 92%).
[00103] The [Et3NH]2[B12Cl12] was suspended in DI water (10 mL) at ambient temperature in a 50 mL round-bottom flask. With stirring, a solution of NaOH (50% in water, 1.5 mL) was added dropwise, and the suspension became a hazy homogeneous solution. The solution was filtered, and the filtrate was concentrated using a rotary evaporator to a volume of ca. 5 mL. To the solution was added DI water (10 mL) and the solution was again concentrated using a rotary evaporator to a volume of ca. 5 mL. The dilution / concentration step was repeated one more time. To the solution was added a solution of cesium chloride (6.6 g, 39.2 mmol) resulting in the precipitation of a white crystalline solid. The suspension was heated until the solid dissolved. White crystals precipitated upon cooling to ambient temperature. The crystalline solid was isolated via filtration and dried under vacuum at 80 °C. 5.91 g. 1H, 13C, and 11B NMR spectroscopy confirmed the identity of the isolated white solid as Cs2[B12Cl12] in 73% yield.
[00104] General Procedure 1
[00105] General Procedure 1: Examples 1-16 and Comparative Example 1-6MeSiCl3 --(Catalyst)--> SiCl4 + Me2SiCl2 + Me3SiCl2(2h, 120 °C; 2h, 150 °C; 2h, 180 °C)and / orMe3SiCl + MeSiCl3 --(Catalyst)--> Me4Si + Me2SiCl2(2h, 120 °C; 2h, 150 °C; 2h, 180 °C)
[00106] In a nitrogen filled glovebox, each Pre-Catalyst (B) was weighed in a glass vial and transferred to a stainless-steel reactor. The reactants (silanes and benzene, or silanes alone) were weighed in a glass vial, and the Pre-Catalyst (B) containing vial was rinsed with the reactants to give a reaction mixture. This reaction mixture was also added to the stainless-steel reactor. The reactor was sealed, and placed on an aluminum heating block. The reaction mixture was heated to 120 °C, and left to react at that temperature for 2 hours after which time heat was turned off and the sample was cooled to room temperature naturally. An aliquot of this sample is dissolved in C6D6 (about 0.8 g) and analyzed by multinuclear NMR spectroscopy (1H, 29Si). The remainder of the reaction mixture was heated to 150 °C, and left to react at that temperature for 2 hours after which time heat is turned off and the sample is cooled to room temperature naturally. An aliquot of this sample was dissolved in C6D6 (about 0.8 g) and analyzed by multinuclear NMR spectroscopy (1H, 29Si). The remainder of the reaction mixture was heated to 180 °C, and left to react at that temperature for 2 hours after which time heat was turned off and the sample is cooled to room temperature naturally. An aliquot of this sample was dissolved in C6D6 (about 0.8 g) and analyzed by multinuclear NMR spectroscopy (1H, 29Si).
[00107] Table 2: Examples 1-16 and Comparative Example 1-6 Masses of Pre-Catalyst and Reactants UsedExample | Pre-Catalyst | Pre-Catalyst (g) | MeSiCl3 (g) | Me3SiCl (g)---|---|---|---|---1 | (B1) | 0.020 | 2.050 | 02 | (B2) | 0.020 | 2.101 | 03 | (B3) | 0.030 | 2.074 | 04 | (B4) | 0.025 | 2.035 | 05 | (B5) | 0.030 | 2.058 | 06 | (B6) | 0.023 | 2.032 | 07 | (B7) | 0.020 | 2.030 | 08 | (B8) | 0.015 | 2.053 | 09 | (B1) | 0.020 | 1.164 | 0.87110 | (B2) | 0.020 | 1.177 | 0.86511 | (B3) | 0.030 | 1.142 | 0.86712 | (B4) | 0.025 | 1.197 | 0.85413 | (B5) | 0.030 | 1.176 | 0.85914 | (B6) | 0.023 | 1.175 | 0.86015 | (B7) | 0.020 | 1.166 | 0.86116 | (B8) | 0.015 | 1.167 | 0.857C. E. 1 | C.(B1) | 0.030 | 2.077 | 0C. E. 2 | C.(B2) | 0.037 | 2.058 | 0C. E. 3 | C.(B3) | 0.030 | 2.110 | 0C. E. 4 | C.(B1) | 0.030 | 1.174 | 0.853C. E. 5 | C.(B2) | 0.036 | 1.185 | 0.855C. E. 6 | C.(B3) | 0.030 | 1.153 | 0.856
[00108] Table 3: Product distribution for Examples 1-8 and Comparative Examples 1-3 (yields in %):Example | Temp (°C) | Me4Si | Me3SiCl | Me2SiCl2 | MeSiCl3---|---|---|---|---|---C. E. 1 | 120 | No Reaction| 150 | | 180 | C. E. 2 | 120 | No Reaction| 150 | | 180 | C. E. 3 | 120 | No Reaction| 150 | | 180 | 1 | 120 | No Reaction| 150 | | 180 | 2 | 120 | 0 | 0.0 | 0.3 | 99.7| 150 | 0 | 0.0 | 0.4 | 99.6| 180 | 0 | 0.0 | 0.5 | 99.53 | 120 | No Reaction| 150 | | 180 | 4 | 120 | 0 | 0.0 | 0.3 | 99.7| 150 | 0 | 0.0 | 0.5 | 99.5| 180 | 0 | 0.0 | 0.5 | 99.55 | 120 | No Reaction| 150 | | 180 | 6 | 120 | 0.0 | 0.0 | 0.2 | 99.8| 150 | 0.0 | 0.0 | 0.4 | 99.6| 180 | 0.0 | 0.0 | 0.4 | 99.67 | 120 | 0.0 | 0.0 | 0.3 | 99.8| 150 | 0.0 | 0.0 | 0.3 | 99.7| 180 | 0.0 | 0.0 | 0.3 | 99.78 | 120 | 0.0 | 0.0 | 1.4 | 98.6| 150 | 0.0 | 0.0 | 1.5 | 98.5| 180 | 0.0 | 0.0 | 1.5 | 98.5
[00109] Table 4: Product distribution for Examples 9-16 and Comparative Examples 4-6 (yields in %):Example | Temp (°C) | Me4Si | Me3SiCl | Me2SiCl2 | MeSiCl3---|---|---|---|---|---C. E. 4 | 120 | No Reaction| 150 | | 180 | C. E. 5 | 120 | No Reaction| 150 | | 180 | C. E. 6 | 120 | No Reaction| 150 | | 180 | 9 | 120 | 1.0 | 46.0 | 2.9 | 50.1| 150 | 0.1 | 44.1 | 9.2 | 46.5| 180 | 0 | 22.3 | 54.2 | 23.510 | 120 | 1.7 | 45.9 | 2.4 | 50.1| 150 | 0.6 | 46.5 | 4.8 | 48.0| 180 | 0.1 | 29.6 | 41.0 | 29.311 | 120 | 1.8 | 45.3 | 3.8 | 49.2| 150 | 1.2 | 44.8 | 6.6 | 47.3| 180 | 0.1 | 31.9 | 36.8 | 31.112 | 120 | 1.9 | 44.9 | 2.6 | 50.7| 150 | 2.9 | 41.8 | 4.4 | 51.0| 180 | 1.3 | 41.7 | 9.4 | 47.513 | 120 | 0.4 | 46.8 | 4.1 | 48.8| 150 | 0.1 | 40.0 | 17.8 | 42.0| 180 | 0 | 13.1 | 73.0 | 13.914 | 120 | 1.5 | 46.2 | 2.5 | 49.8| 150 | 0.8 | 38.4 | 20.3 | 40.5| 180 | 0 | 26.8 | 46.0 | 27.215 | 120 | 0.1 | 33.3 | 28.9 | 37.8| 150 | 0.0 | 26.2 | 43.8 | 30.0| 180 | 0.0 | 22.7 | 50.8 | 26.416 | 120 | 0.2 | 42.6 | 14.3 | 42.9| 150 | 0.2 | 36.3 | 26.2 | 37.3| 180 | 0.2 | 34.1 | 30.8 | 35.0
[00110] The invention has been described in an illustrative manner, and it was to be understood that the terminology which has been used was intended to be in the nature of words of description rather than of limitation. Obviously, many modifications and variations of the present invention are possible in light of the above teachings. The invention may be practiced otherwise than as specifically described.
Claims
What is claimed is:
1. A method of preparing a target compound, said method comprising:combining (A) an organosilicon component and (B) a catalyst comprising a boron cluster to give a mixture; andpreparing a reaction mixture comprising the target compound from the mixture;wherein the organosilicon component (A) comprises (A1) a first organosilicon compound having at least one silicon-bonded C1-C4 alkyl group and optionally at least one silicon-bonded halogen atom, with the proviso that when the first organosilicon compound (A1) does not include a silicon-bonded halogen atom, the organosilicon component (A) further comprises a second organosilicon compound (A2) including at least one silicon-bonded halogen atom;wherein the target compound is different from the first organosilicon compound (A1) and, if utilized, the second organosilicon compound (A2); andwherein the catalyst (B) is capable of facilitating the exchange of one silicon-bonded alkyl group of a first silane molecule with a silicon-bonded halogen atom of a second silane molecule;wherein the boron cluster comprises a plurality of boron atoms and one carbon atom.
2. The method of claim 1, wherein the target compound has the general formula Rx'Hy'Q4-x'-y'Si, where each R is an independently selected alkyl group having from 1 to 4 carbon atoms, each Q is an independently selected halogen atom, 1≤x≤3, 0≤y'≤2, and x'+y' is from 1 to 4.
3. The method of claim 1 or 2, wherein the first organosilicon compound (A1) has the general formula RxHyQzSi, where each R is an independently selected alkyl group having from 1 to 4 carbon atoms, each Q is an independently selected halogen atom, 1≤x≤4, 0≤y≤2, 1≤z≤3 and x+y+z=4.
4. The method of any one preceding claim, wherein the catalyst (B) comprises a salt comprising one monoanion having a charge of -1 and one cation, wherein the one monoanion comprises the boron cluster.
5. The method of claim 4, wherein the one monoanion has the formula (CBaXb), where subscript a is 9 or 11, subscripts b=(a+1), wherein each X is independently selected from halogen atoms; H; hydrocarbyl groups; -SiR13 groups, where each R1 is independently a hydrocarbyl group, H or a halogen atom; -OR2 groups, where each R2 is independently H, an alkyl group, or a silyl group.
6. The method of claim 4 or 5, wherein the cation of the salt of the catalyst (B) is a Brønsted or Lewis acid.
7. The method of claim 6, wherein the cation comprises a Brønsted acid, and wherein the cation comprises a proton, which may optionally be associated with a molecule.
8. The method of claim 7, wherein the cation comprises the proton, and wherein the proton is associated with a silane compound, a hydrocarbon, or a molecule having the general formula Z-O-Z, where each Z is independently selected from H, a silyl group, and a hydrocarbyl group.
9. The method of claim 6, wherein the cation comprises a Lewis acid.
10. The method of claim 9, wherein the Lewis acid comprises a silylium cation or a carbocation.
11. The method of claim 10, wherein the Lewis acid comprises the silylium cation; wherein the silylium cation has the formula (R4)3Si+, where each R4 is independently selected from H, a substituted or unsubstituted hydrocarbyl group, and a halogen atom; and wherein the silylium cation is optionally associated with a silane compound, a hydrocarbon, or a molecule having the general formula Z-O-Z, where each Z is independently selected from H, a silyl group, and a hydrocarbyl group.
12. The method of claim 11, where each R4 is an independently selected alkyl or aryl group.
13. The method of any one preceding claim, wherein the method comprises combining the organosilicon component (A) and a pre-catalyst (B1) different from the catalyst (B), and wherein the catalyst (B) is formed in situ in the presence of the organosilicon component (A).
14. The method of any one preceding claim, carried out at a temperature of from room temperature to 220 °C.
15. The method of any one preceding claim, wherein: (i): the first organosilicon compound (A1) comprises Me4Si, Me3SiCl, MeSiCl3 or Me2SiCl2 where Me indicates methyl; or (ii) the organosilicon component (A) further comprises the second organosilicon compound (A2), wherein the second organosilicon compound (A2) comprises MeSiCl3, Me2SiCl2, or SiCl4.
16. The method of any one of claims 1-14, wherein the first organosilicon compound (A1) comprises MeSiCl3 or Me2SiCl2, where Me indicates methyl.
17. The method of any one of claims 1-14, wherein:(i) the first organosilicon compound (A1) consists essentially of MeSiCl3, where Me indicates methyl; or(ii) the first organosilicon compound (A1) consists essentially of Me2SiCl2; or(iii) the first organosilicon compound (A1) comprises MeSiCl3, and wherein the organosilicon component (A) further comprises the second organosilicon compound (A2), where the second organosilicon compound (A2) comprises Me2SiCl2; or(iv) the first organosilicon compound (A1) comprises Me4Si, and wherein the organosilicon component (A) further comprises the second organosilicon compound (A2), where the second organosilicon compound (A2) comprises MeSiCl3; or(v) the first organosilicon compound (A1) comprises MeSiCl3, and wherein the organosilicon component (A) further comprises the second organosilicon compound (A2), where the second organosilicon compound (A2) comprises Me3SiCl.
18. The method of any one preceding claim, further comprising isolating the target compound from the reaction product.
19. The reaction product comprising the target compound prepared in accordance with the method of any one preceding claim.
